Shan Yang is a Vice President with experience commercializing genomics and diagnostic technologies. She led U.S. market entry for spatial transcriptomics at Complete Genomics and held roles at Illumina and Invitae.
At firms with a similar stage, sector and check size.
One email when Shan's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckShan Yang is a Vice President with experience commercializing genomics and diagnostic technologies. She led U.S. market entry for spatial transcriptomics at Complete Genomics and held roles at Illumina and Invitae.
Shan Yang invests through Joyance Partners, which writes checks of $100K to $250K at pre-seed, seed, series a.
A warm intro from a founder Joyance Partners backed works best.
Complete Genomics; Illumina; Invitae.
Last updated 2026-10-15. Is this you? Ask for a correction.